- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
September 12th, 2007
New nanoemulsion safely treats serious skin infections without systemic side effects
A new topical lotion that penetrates the skin deeply enough to target and eliminate serious skin infections, but without being systemically absorbed, has shown a high degree of safety and tolerability in patients with onychomycosis, or toenail fungus, a new study has shown.
"Results of the phase 1 clinical trial are important to the fields of dermatology and infectious diseases because currently approved systemic medications for onychomycosis carry serious risks of cardiac and liver toxicity," said James Baker, MD, chief science officer and founder of NanoBio Corporation in Ann Arbor, Mich.
|Related News Press|
Graphenea celebrates fifth anniversary April 27th, 2015